Jan 20, 2026 10:15am EST MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
Dec 24, 2025 8:01am EST MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
